SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Torrent Pharma zooms on reporting 75% rise in Q1 consolidated net profit

28 Jul 2015 Evaluate

Torrent Pharmaceuticals is currently trading at Rs 1474.45, up by 77.45 points or 5.54% from its previous closing of Rs 1397.00 on the BSE.

The scrip opened at Rs. 1510.00 and has touched a high and low of Rs. 1520.00 and Rs. 1462.50 respectively. So far 74634 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1520.00 on 27-Jul-2015 and a 52 week low of Rs. 698.00 on 28-Jul-2014.

Last one week high and low of the scrip stood at Rs. 1520.00 and Rs. 1324.00 respectively. The current market cap of the company is Rs. 24924.81 crore.

The promoters holding in the company stood at 71.25% while Institutions and Non-Institutions held 19.09% and 9.66% respectively.

Torrent Pharmaceuticals has reported over two and a half fold jump in net profit at Rs 830 crore for the quarter ended June 30, 2015 as compared to Rs 305 crore for the same quarter in the previous year. The company’s total income has surged two fold to Rs 1942 crore for the quarter under review from Rs 973 crore for the corresponding quarter of the previous year.

On the consolidated basis, the company has reported 75.39% rise in its net profit after taxes and minority interest at Rs 449 crore for the quarter ended June 30, 2015 as compared to Rs 256 crore for the same quarter in the previous year. Total income of the company has increased by 73.17% at Rs 2014 crore for quarter under review as compared to Rs 1163 crore for the quarter ended June 30, 2014.

Torrent Pharma Share Price

4178.85 22.50 (0.54%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×